Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Emergency aid for overdoses

  • Improving bladder function among people with spinal cord injuries

  • Blinded by non-science: Trivial scientific information increases trust in products

  • Pathological gambling is associated with altered opioid system in the brain

  • Highly connected CEOs more likely to broker mergers and acquisitions that harm firms, study shows

  • Heart rate may predict survival, brain function in comatose cardiac arrest survivors

  • Cold sores increase risk of dementia, research suggests

  • User-friendly electronic 'Eyecane' enhances navigational abilities for blind

  • Design of micro, nanoparticles to improve treatments for Alzheimer's, Parkinson's

  • Sexual preference for masculine men, feminine women is an urban habit

  •